Founders Financial Securities’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.11M | Buy |
2,710
+13
| +0.5% | +$10.1K | 0.16% | 123 |
|
|
2025
Q1 | $2.37M | Buy |
2,697
+1,034
| +62% | +$907K | 0.2% | 105 |
|
|
2024
Q4 | $1.28M | Buy |
1,663
+99
| +6% | +$76.4K | 0.12% | 154 |
|
|
2024
Q3 | $1.39M | Sell |
1,564
-907
| -37% | -$803K | 0.13% | 142 |
|
|
2024
Q2 | $2.24M | Buy |
2,471
+987
| +67% | +$893K | 0.21% | 98 |
|
|
2024
Q1 | $1.15M | Sell |
1,484
-740
| -33% | -$576K | 0.12% | 148 |
|
|
2023
Q4 | $1.3M | Buy |
2,224
+1,043
| +88% | +$608K | 0.14% | 127 |
|
|
2023
Q3 | $634K | Sell |
1,181
-172
| -13% | -$92.4K | 0.08% | 184 |
|
|
2023
Q2 | $635K | Sell |
1,353
-512
| -27% | -$240K | 0.08% | 184 |
|
|
2023
Q1 | $640K | Buy |
1,865
+1,122
| +151% | +$385K | 0.09% | 174 |
|
|
2022
Q4 | $272K | Sell |
743
-46
| -6% | -$16.8K | 0.04% | 267 |
|
|
2022
Q3 | $255K | Buy |
+789
| New | +$255K | 0.05% | 254 |
|
|
2017
Q1 | – | Sell |
-5,066
| Closed | -$373K | – | 105 |
|
|
2016
Q4 | $373K | Buy |
+5,066
| New | +$373K | 0.16% | 64 |
|
|
2015
Q1 | – | Sell |
-42,719
| Closed | -$2.95M | – | 84 |
|
|
2014
Q4 | $2.95M | Buy |
42,719
+2,972
| +7% | +$205K | 1.76% | 12 |
|
|
2014
Q3 | $2.58M | Buy |
39,747
+4,227
| +12% | +$274K | 1.66% | 16 |
|
|
2014
Q2 | $2.21M | Buy |
35,520
+5,365
| +18% | +$334K | 1.48% | 15 |
|
|
2014
Q1 | $1.78K | Buy |
30,155
+5,744
| +24% | +$338 | 1.19% | 20 |
|
|
2013
Q4 | $1.25M | Buy |
+24,411
| New | +$1.25M | 1.04% | 26 |
|